Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Innovent Biologics (suzhou) Co. Ltd.

Clinical trials sponsored by Innovent Biologics (suzhou) Co. Ltd., explained in plain language.

Now part of Innovent Biologics, Inc. 1801 HKEX

Biopharmaceutical company developing and commercializing monoclonal antibody drugs.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 18 Not yet recruiting 10 Not yet finished but already full! 10 Completed 16 Terminated 1

Promising cancer drug trial halted early – only 5 patients enrolled

Disease control Terminated

This early-phase trial tested an experimental drug called IBI3004 in people with advanced solid tumors that could not be removed by surgery. The study aimed to find a safe dose and check for side effects, but it was terminated after enrolling only 5 participants. Because it stopp…

Phase: PHASE1, PHASE2 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Disease control

Last updated Jun 27, 2026 08:07 UTC